The Alzheimer’s disease mitochondrial cascade hypothesis: progress and perspectives

Swerdlow, Russell H., Burns, Jeffrey M., Khan, Shaharyar M.·2014·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
DOI 10.1016/j.bbadis.2013.09.010

Cited by (786)

Items 101–200 of 786

  1. Insights into Disease-Associated Tau Impact on Mitochondria
    Leonora Szabo, Anne Eckert, Amandine Grimm · 2020 · International Journal of Molecular Sciences
  2. The Role of Mitochondrial Calcium Homeostasis in Alzheimer’s and Related Diseases
    Kerry C. Ryan, Zahra Ashkavand, Kenneth R. Norman · 2020 · International Journal of Molecular Sciences
  3. Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer’s Disease Multitarget Drug Discovery?: Miniperspective
    De Simone, Angela, Tumiatti, Vincenzo, Andrisano, Vincenza, Milelli, Andrea · 2021 · Journal of Medicinal Chemistry
  4. Recent Advances in Molecular Pathways and Therapeutic Implications Targeting Mitochondrial Dysfunction for Alzheimer’s Disease
    Rishika Dhapola, Phulen Sarma, Bikash Medhi, Ajay Prakash, Dibbanti HariKrishnaReddy · 2021 · Molecular Neurobiology
  5. Impaired mitochondrial energy metabolism in Alzheimer's disease: Impact on pathogenesis via disturbed epigenetic regulation of chromatin landscape
    Antero Salminen, Annakaisa Haapasalo, Anu Kauppinen, Kai Kaarniranta, Hilkka S. Soininen, Mikko O. Hiltunen · 2015 · Progress in Neurobiology
  6. Microglial mitophagy mitigates neuroinflammation in Alzheimer's disease
    Lautrup, Sofie, Lou, Guofeng, Aman, Yahyah, Nilsen, Hilde, Tao, Jun, Fang, Evandro F. · 2019 · Neurochemistry International
  7. Sustained O-GlcNAcylation reprograms mitochondrial function to regulate energy metabolism
    Ee Phie Tan, Steven R. McGreal, Stefan Graw, Robert T. Tessman, Scott J. Koppel, Pramod Dhakal, Zhen Zhang, Miranda E. Machacek, Natasha Elizabeth Zachara, Devin C. Koestler et al. · 2017 · Journal of Biological Chemistry
  8. Alzheimer’s disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery?
    Kevin Mullane, Michael J. Williams · 2020 · Biochemical Pharmacology
  9. Mammalian AKT, the Emerging Roles on Mitochondrial Function in Diseases
    Xiaoxian Xie, Ruonan Shu, Chunan Yu, Zhengwei Fu, Zezhi Li · 2022 · Aging and Disease
  10. Mitochondrial respiration as a target for neuroprotection and cognitive enhancement
    Francisco Gonzalez-Lima, Bryan R. Barksdale, Julio C. Rojas · 2013 · Biochemical Pharmacology
  11. Sex hormone-related neurosteroids differentially rescue bioenergetic deficits induced by amyloid-β or hyperphosphorylated tau protein
    Amandine Grimm, Emily E. Biliouris, Undine Emmi Lang, Jürgen Götz, Ayikoe Guy Mensah‐Nyagan, Anne Eckert · 2015 · Cellular and Molecular Life Sciences
  12. Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region
    Mukta Agrawal, Swarnlata Saraf, Shailendra Saraf, Sophia G. Antimisiaris, Nobuhito Hamano, Shyh‐Dar Li, Mahavir Bhupal Chougule, Sunday Shoyele, Umesh Dutta Gupta, M. Ajazuddin et al. · 2018 · Expert Opinion on Drug Delivery
  13. Mitochondria in Alzheimer's disease and their potential role in Alzheimer's proteostasis
    Ian W. Weidling, Russell Howard Swerdlow · 2020 · Experimental Neurology
  14. Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer’s disease pathology
    Scheff, Stephen W., Ansari, Mubeen A., Mufson, Elliott J. · 2016 · Neurobiology of Aging
  15. Estrogen receptor β in Alzheimer’s disease: From mechanisms to therapeutics
    Liqin Zhao, Sarah K. Woody, Anindit Chhibber · 2015 · Ageing Research Reviews
  16. Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer’s disease protects against mitochondrial dysfunction and mitigates brain pathology
    Ankit Verma, Anna Shteinfer‐Kuzmine, Nikita Kamenetsky, Srinivas Pittala, Avijit Paul, Edna Nahon Crystal, Alberto Ouro, Vered Chalifa Caspi, Swaroop Kumar Pandey, Alon Monsonego et al. · 2022 · Translational Neurodegeneration
  17. Mitochondrial Dysfunction: A Key Player in Brain Aging and Diseases
    Sydney Bartman, Giuseppe Coppotelli, Jaime M. Ross · 2024 · Current Issues in Molecular Biology
  18. Alzheimer’s disease (AD) therapeutics – 1: Repeated clinical failures continue to question the amyloid hypothesis of AD and the current understanding of AD causality
    Mullane, Kevin, Williams, Michael · 2018 · Biochemical Pharmacology
  19. Mitochondria-Targeted, Nanoparticle-Based Drug-Delivery Systems: Therapeutics for Mitochondrial Disorders
    Sakshi Buchke, Muskan Sharma, Anusuiya Bora, Maitrali Relekar, Piyush Bhanu, Jitendra Kumar · 2022 · Life
  20. Effects of a ketogenic and low‐fat diet on the human metabolome, microbiome, and foodome in adults at risk for Alzheimer's disease
    Amanda Hazel Dilmore, Cameron Martino, Bryan J. Neth, Kiana West, Jasmine Zemlin, Gibraan Rahman, Morgan W. Panitchpakdi, Michael J. Meehan, Kelly C. Weldon, Colette Blach et al. · 2023 · Alzheimer s & Dementia
  21. Pilot feasibility and safety study examining the effect of medium chain triglyceride supplementation in subjects with mild cognitive impairment: A randomized controlled trial
    Candida Joan Rebello, Jeffrey N. Keller, Ann G. Liu, William D. Johnson, Frank L. Greenway · 2015 · BBA Clinical
  22. Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing
    Jiansong Fang, Andrew A. Pieper, Ruth Nussinov, Garam Lee, Lynn M. Bekris, James B. Leverenz, Jeffrey L. Cummings, Feixiong Cheng · 2020 · Medicinal Research Reviews
  23. Hippocampal proteomics defines pathways associated with memory decline and resilience in ‘normal’ aging and Alzheimer’s disease mouse models
    S. Neuner, L. Wilmott, B. Hoffmann, K. Mozhui, C. Kaczorowski · 2016 · Behavioural Brain Research
  24. Dementia in Parkinson's disease is associated with enhanced mitochondrial complex I deficiency
    Ariana P. Gatt, Olivia F. Duncan, Johannes Attems, Paul T. Francis, Clive G. Ballard, J.E. Bateman · 2016 · Movement Disorders
  25. Carbonic anhydrase inhibition selectively prevents amyloid β neurovascular mitochondrial toxicity
    Solesio, María E., Peixoto, Pablo M., Debure, Ludovic, Madamba, Stephen M., de Leon, Mony J., Wisniewski, Thomas, Pavlov, Evgeny V., Fossati, Silvia · 2018 · Aging Cell
  26. Jujuboside A, a neuroprotective agent from semen Ziziphi Spinosae ameliorates behavioral disorders of the dementia mouse model induced by Aβ1–42
    Zhi Liu, Xu Dong Zhao, Bing Liu, Aijing Liu, Huan Li, Xin Mao, Bo Ming Wu, BI Kai-shun, Ying Jia · 2014 · European Journal of Pharmacology
  27. Microbiota-gut-brain axis and toll-like receptors in Alzheimer’s disease
    Caixiu Lin, Shuai Zhao, Yueli Zhu, Ziqi Fan, Jing Wang, Baorong Zhang, Yanxing Chen · 2019 · Computational and Structural Biotechnology Journal
  28. Endothelial dysfunction and its relation in different disorders: Recent update
    Adarsh Ray, Krushna Ch Maharana, Sarasa Meenakshi, Sanjiv Singh · 2023 · Health Sciences Review
  29. Astrocytes autophagy in aging and neurodegenerative disorders
    Jun‐Ling Wang, Chao‐Jin Xu · 2019 · Biomedicine & Pharmacotherapy
  30. Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease
    Steven N. Austad, Scott W. Ballinger, Thomas W. Buford, Christy S. Carter, Daniel L. Smith, Victor M. Darley-Usmar, Jianhua Zhang · 2021 · Acta Pharmaceutica Sinica B
  31. Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots
    Shao-Hua Yang, Wenjun Li, Nathalie Sumien, Michael J. Forster, James W. Simpkins, Ran Liu · 2015 · Progress in Neurobiology
  32. Neuroprotective effects of verbascoside against Alzheimer’s disease via the relief of endoplasmic reticulum stress in Aβ-exposed U251 cells and APP/PS1 mice
    Chunyue Wang, Xueying Cai, Ruochen Wang, Siyu Zhai, Yongfeng Zhang, Wenji Hu, Yizhi Zhang, Di Wang · 2020 · Journal of Neuroinflammation
  33. Targeting the Prodromal Stage of Alzheimer's Disease: Bioenergetic and Mitochondrial Opportunities
    Charles C. Caldwell, Jia Yao, Roberta Dı́az Brinton · 2014 · Neurotherapeutics
  34. Mitochondrial Dysfunction
    Kristina Leuner, Carola Stockburger, Isabel Denzer, Gunter Peter Eckert, Walter E. Müller · 2014 · Progress in molecular biology and translational science
  35. Melatonin induces mechanisms of brain resilience against neurodegeneration
    Rubén Corpas, Christian Griñán‐Ferré, Verónica Palomera‐Ávalos, David Porquet, Pablo Garcı́a de Frutos, Silvia M. Franciscato Cozzolino, Eduard Rodrı́guez-Farré, Mercè Pallàs, Coral Sanfeliu, Bárbara Rita Cardoso · 2018 · Journal of Pineal Research
  36. The mitochondrial hypothesis: Dysfunction, bioenergetic defects, and the metabolic link to Alzheimer's disease
    Russell Howard Swerdlow · 2020 · International review of neurobiology
  37. Cell-Membrane-Coated Nanoparticles for Targeted Drug Delivery to the Brain for the Treatment of Neurological Diseases
    Li, Jianzhuang, Wei, Yanhao, Zhang, Chunlin, Bi, Rentang, Qiu, Yanmei, Li, Yanan, Hu, Bo · 2023 · Pharmaceutics
  38. Induced pluripotent stem cells in Alzheimer’s disease: applications for disease modeling and cell-replacement therapy
    Juan Yang, Song Li, Xi‐Biao He, Cheng Cheng, Weidong Le · 2016 · Molecular Neurodegeneration
  39. Protein Phosphorylation is a Key Mechanism in Alzheimer’s Disease
    Joana Machado Oliveira, Márcio Gilberto Cardoso Costa, Maria Cachide, Odete A. B. da Cruz e Silva, Ana Gabriela Henriques · 2017 · Journal of Alzheimer s Disease
  40. Microvascular Alterations in Alzheimer's Disease
    Joe Steinman, Hong‐Shuo Sun, Zhong‐Ping Feng · 2021 · Frontiers in Cellular Neuroscience
  41. Mitochondrial Dysfunction in Neurodegenerative Diseases
    Han‐Mo Yang · 2025 · Cells
  42. SIRT3 activator Honokiol attenuates β-Amyloid by modulating amyloidogenic pathway
    Sindhu Ramesh, Manoj Govindarajulu, Tyler O. Lynd, Gwyneth Helen Briggs, Danielle Adamek, Ellery Jones, Jake Heiner, Mohammed Majrashi, Timothy Moore, Rajesh Amin et al. · 2018 · PLoS ONE
  43. Protective effect of exercise training against the progression of Alzheimer’s disease in 3xTg-AD mice
    Donghyun Kim, Jinkyung Cho, Hyun‐Sik Kang · 2019 · Behavioural Brain Research
  44. Multitarget Strategies in Alzheimer’S Disease: Benefits and Challenges on the Road to Therapeutics
    Michela Rosini, Elena Simoni, Roberta Caporaso, Anna Minarini · 2016 · Future Medicinal Chemistry
  45. Circular RNA NF1-419 enhances autophagy to ameliorate senile dementia by binding Dynamin-1 and Adaptor protein 2 B1 in AD-like mice
    Chen Diling, Yinrui Guo, Longkai Qi, Tang Xiaocui, Yadi Liu, Yang Xin, Hu Guoyan, Ou Shuai, Tianqiao Yong, Dongdong Wang et al. · 2019 · Aging · Retracted
  46. Alzheimer’s Disease: Pathogenesis and Therapeutic Interventions
    John Onyebuchi Ogbodo, Chinazom Precious Agbo, Ugochi Olivia Njoku, Martins Obinna Ogugofor, Simeon Ikechukwu Egba, Stella Amarachi Ihim, Adaeze Chidiebere Echezona, Kenneth C. Brendan, Aman Babanrao Upaganlawar, Chandrashekhar Devidas Upasani · 2021 · Current Aging Science
  47. The Alzheimer’s Disease Mitochondrial Cascade Hypothesis: A Current Overview
    Russell Howard Swerdlow · 2023 · Journal of Alzheimer s Disease
  48. Type 2 Diabetes Mellitus Increases the Risk of Late-Onset Alzheimer’s Disease: Ultrastructural Remodeling of the Neurovascular Unit and Diabetic Gliopathy
    Melvin Ray Hayden · 2019 · Brain Sciences
  49. Mitochondrial Sirt3 Expression is Decreased in APP/PS1 Double Transgenic Mouse Model of Alzheimer’s Disease
    Wenxiu Yang, Yan Zou, Man Zhang, Nan Zhao, Qi Tian, Min Gu, Wei Liu, Rui Shi, Yang Lü, Weihua Yu · 2015 · Neurochemical Research
  50. An antioxidant specifically targeting mitochondria delays progression of Alzheimer’s disease-like pathology
    Natalia A. Stefanova, Natalia A. Muraleva, Kseniya Yi. Maksimova, Ekaterina A. Rudnitskaya, Киселева Елена Владимировна, Darya V. Telegina, Nataliya G. Kolosova · 2016 · Aging
  51. Interplay between Peripheral and Central Inflammation in Obesity-Promoted Disorders: The Impact on Synaptic Mitochondrial Functions
    Marianna Crispino, Giovanna Trinchese, Eduardo Penna, Fabiano Cimmino, Angela Catapano, Ines Villano, Carla Perrone‐Capano, Maria Pina Mollica · 2020 · International Journal of Molecular Sciences
  52. Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs
    Lozupone, Madia, Solfrizzi, Vincenzo, D’Urso, Francesca, Di Gioia, Ilaria, Sardone, Rodolfo, Dibello, Vittorio, Stallone, Roberta, Liguori, Angelo, Ciritella, Chiara, Daniele, Antonio et al. · 2020 · Expert Opinion on Emerging Drugs
  53. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer’s Disease
    Angie K. Torres, Claudia Jara, Han S. Park-Kang, Catalina M. Polanco, Diego Tapia, Fabián Alarcón, Adely de la Peña, Jesús Llanquinao, Gabriela Vargas-Mardones, Javiera Álvarez‐Indo et al. · 2021 · Journal of Alzheimer s Disease
  54. Quercetin Exerts Differential Neuroprotective Effects Against H2O2 and Aβ Aggregates in Hippocampal Neurons: the Role of Mitochondria
    Juan Alejandro Godoy, Carolina B. Lindsay, Rodrigo A. Quintanilla, Francisco J. Carvajal, Waldo F. Cerpa, Nibaldo C. Inestrosa · 2016 · Molecular Neurobiology
  55. In situ fibrillizing amyloid-beta 1-42 induces neurite degeneration and apoptosis of differentiated SH-SY5Y cells
    Jekaterina Krishtal, Olga Bragina, Kristel Metsla, Peep Palumaa, Vello Tõugu · 2017 · PLoS ONE
  56. Mitophagy alterations in Alzheimer's disease are associated with granulovacuolar degeneration and early tau pathology
    Xu Hou, Jens O. Watzlawik, Casey N. Cook, Chia‐Chen Liu, Silvia S. Kang, Wen‐Lang Lin, Michael A. Deture, Michael G. Heckman, Nancy N. Diehl, Fadi S. Hanna Al‐Shaikh et al. · 2020 · Alzheimer s & Dementia
  57. RETRACTED: Mitophagy enhancers against phosphorylated Tau-induced mitochondrial and synaptic toxicities in Alzheimer disease
    Sudhir Kshirsagar, Neha A. Sawant, Hallie Morton, Arubala P. Reddy, P. Hemachandra Reddy · 2021 · Pharmacological Research · Retracted
  58. New Drugs from Marine Organisms in Alzheimer’s Disease
    Patrizia Russo, Aliaksei Kisialiou, Palma Lamonaca, Rossana Moroni, Giulia Prinzi, Massimo Fini · 2015 · Marine Drugs
  59. Mitochondria-associated membranes (MAMs): a potential therapeutic target for treating Alzheimer’s disease
    Weiwei Yu, Haiqiang Jin, Yining Huang · 2021 · Clinical Science
  60. Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives
    Chiara Lanzillotta, Fabio Di Domenico, Marzia Perluigi A, David Allan Butterfield · 2019 · CNS Drugs
  61. Mitochondrial dysfunction and beneficial effects of mitochondria-targeted small peptide SS-31 in Diabetes Mellitus and Alzheimer’s disease
    Xiao-Wen Ding, Megan Robinson, Rongzi Li, Hadeel Aldhowayan, Thangiah Geetha, Jeganathan Ramesh Babu · 2021 · Pharmacological Research
  62. Honokiol Alleviates Cognitive Deficits of Alzheimer’s Disease (PS1 V97L ) Transgenic Mice by Activating Mitochondrial SIRT3
    Haitao Li, Jianping Jia, Wei Wang, Tingting Hou, Yuanruhua Tian, Qiaoqi Wu, Lingzhi Xu, Yiping Wei, Xiu Wang · 2018 · Journal of Alzheimer s Disease
  63. An Unbalanced Synaptic Transmission: Cause or Consequence of the Amyloid Oligomers Neurotoxicity?
    Sciaccaluga, Miriam, Megaro, Alfredo, Bellomo, Giovanni, Ruffolo, Gabriele, Romoli, Michele, Palma, Eleonora, Costa, Cinzia · 2021 · International Journal of Molecular Sciences
  64. Mitochondrial Abnormalities and Synaptic Loss Underlie Memory Deficits Seen in Mouse Models of Obesity and Alzheimer’s Disease
    Isaura V.A. Martins, Jack Rivers‐Auty, Stuart McRae Allan, Catherine B. Lawrence · 2016 · Journal of Alzheimer s Disease
  65. Microbial BMAA elicits mitochondrial dysfunction, innate immunity activation, and Alzheimer’s disease features in cortical neurons
    Diana Filipa Silva, Emanuel Candeias, A. Raquel Esteves, João Duarte Magalhães, Ildete L. Ferreira, Daniela Nunes‐Costa, Ana Cristina Rego, Nuno Empadinhas, Sandra M. Cardoso · 2020 · Journal of Neuroinflammation
  66. Dissecting Complex and Multifactorial Nature of Alzheimer’s Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective
    Puneet Talwar, Juhi Sinha, Sandeep Grover, Chitra Rawat, Suman S. Kushwaha, Rachna Agarwal, Vibha Taneja, Ritushree Kukreti · 2015 · Molecular Neurobiology
  67. Neuroprotective Effects of Icariin on Brain Metabolism, Mitochondrial Functions, and Cognition in Triple‐Transgenic Alzheimer's Disease Mice
    Yi‐Jing Chen, Hai‐Yang Zheng, Xiuxian Huang, Shuangxue Han, Dongsheng Zhang, Jiazuan Ni, Xiaoyang He · 2015 · CNS Neuroscience & Therapeutics
  68. The contribution of biophysical and structural studies of protein self-assembly to the design of therapeutic strategies for amyloid diseases
    Nunilo Cremades, Christopher Martin Dobson · 2017 · Neurobiology of Disease
  69. Dysfunction of mitochondria: Implications for Alzheimer's disease
    Benedict C. Albensi · 2019 · International review of neurobiology
  70. Retracted: Protective effects of mitophagy enhancers against amyloid beta-induced mitochondrial and synaptic toxicities in Alzheimer disease
    Sudhir Kshirsagar, Neha A. Sawant, Hallie Morton, Arubala P. Reddy, P. Hemachandra Reddy · 2021 · Human Molecular Genetics · Retracted
  71. Drosophila Models of Alzheimer's Disease: Advances, Limits, and Perspectives
    Sylvina Bouleau, Hervé Tricoire · 2015 · Journal of Alzheimer s Disease
  72. Changes in Expression Profiles Revealed by Transcriptomic Analysis in Peripheral Blood Mononuclear Cells of Alzheimer’s Disease Patients
    Giovana da Silva Leandro, Adriane Feijó Evangelista, Rômulo Rebouças Lôbo, Danilo J. Xavier, Júlio César Moriguti, Elza Tiemi Sakamoto‐Hojo · 2018 · Journal of Alzheimer s Disease
  73. A single-cell and spatial RNA-seq database for Alzheimer’s disease (ssREAD)
    Wang, Cankun, Acosta, Diana, McNutt, Megan, Bian, Jiang, Ma, Anjun, Fu, Hongjun, Ma, Qin · 2024 · Nature Communications
  74. Influence of JuA in evoking communication changes between the small intestines and brain tissues of rats and the GABAA and GABAB receptor transcription levels of hippocampal neurons
    Xixi Wang, Guijie Ma, Junbo Xie, Guangchang Pang · 2014 · Journal of Ethnopharmacology
  75. Synthesis and metabolism of methylglyoxal, S-D-lactoylglutathione and D-lactate in cancer and Alzheimer’s disease. Exploring the crossroad of eternal youth and premature aging
    Lidia de BARI, Anna Atlante, Tatiana Armeni, Miklós Péter Kalapos · 2019 · Ageing Research Reviews
  76. Mitochondrial DNA haplogroup B5 confers genetic susceptibility to Alzheimer's disease in Han Chinese
    Rui Bi, Wen Zhang, Dandan Yu, Xiao Li, Hui-Zhen Wang, Qiu-Xiang Hu, Chen Zhang, Weihong Lu, Jianliang Ni, Yiru Fang et al. · 2014 · Neurobiology of Aging
  77. Alzheimer's Disease: From Mitochondrial Perturbations to Mitochondrial Medicine
    Susana Cardoso, Cristina Carvalho, Sónia C. Correia, Raquel Maria Fino Seiça, Paula Isabel Moreira · 2016 · Brain Pathology
  78. β-Amyloid Precursor Protein Intracellular Domain Controls Mitochondrial Function by Modulating Phosphatase and Tensin Homolog-Induced Kinase 1 Transcription in Cells and in Alzheimer Mice Models.
    T. Goiran, E. Duplan, M. Chami, A. Bourgeois, Wejdane Elmanaa, Lila Rouland, J. Dunys, Inger Lauritzen, H. You, V. Stambolic et al. · 2017 · Biological Psychiatry
  79. Near-infrared light reduces β-amyloid-stimulated microglial toxicity and enhances survival of neurons: mechanisms of light therapy for Alzheimer’s disease
    Yurii V. Stepanov, Iuliia Golovynska, Renlong Zhang, Sergii Golovynskyi, L. I. Stepanova, Oleksandr I. Gorbach, Taisa Dovbynchuk, L. Garmanchuk, Tymish Y. Ohulchanskyy, Junle Qu · 2022 · Alzheimer s Research & Therapy
  80. Targeting dynamin-related protein-1 as a potential therapeutic approach for mitochondrial dysfunction in Alzheimer's disease
    Jasvinder Singh Bhatti, Satinder Kaur, Jayapriya Mishra, Dibbanti HariKrishnaReddy, Arti Singh, Arubala P. Reddy, Gurjit Kaur Bhatti, P. Hemachandra Reddy · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  81. Recent Expansions on Cellular Models to Uncover the Scientific Barriers Towards Drug Development for Alzheimer’s Disease
    Sunil Kumar Dubey, Siva Ram Munnangi, Kowthavarapu Venkata Krishna, Ranendra Narayan Saha, Gautam Singhvi, Mukta Agrawal, M. Ajazuddin, Swarnlata Saraf, Shailendra Saraf, Amit Alexander · 2019 · Cellular and Molecular Neurobiology
  82. Roles of Non-Coding RNA in Alzheimer’s Disease Pathophysiology
    Edward O. Olufunmilayo, R. M. Damian Holsinger · 2023 · International Journal of Molecular Sciences
  83. Review on anti-alzheimer drug development: approaches, challenges and perspectives
    Abdallah E. Abdallah · 2024 · RSC Advances
  84. The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?
    Mark John Millan · 2014 · Dialogues in Clinical Neuroscience
  85. Potential Links between Impaired One-Carbon Metabolism Due to Polymorphisms, Inadequate B-Vitamin Status, and the Development of Alzheimer’s Disease
    Barbara Troesch, Peter Weber, M. Hasan Mohajeri · 2016 · Nutrients
  86. Activities of mitochondrial respiratory chain complexes in platelets of patients with Alzheimer's disease and depressive disorder
    Zdeněk Fišar, Hana Hansíková, Jana Křížová, Roman Jirák, Eva Kitzlerová, Martina Zvěřová, Jana Hroudová, László Wenchich, J Zeman, Jiří Raboch · 2019 · Mitochondrion
  87. Reassessment of Pioglitazone for Alzheimer’s Disease
    Ann M. Saunders, Daniel K. Burns, William Kirby Gottschalk · 2021 · Frontiers in Neuroscience
  88. Therapeutic Potential of Mitophagy-Inducing Microflora Metabolite, Urolithin A for Alzheimer’s Disease
    Dona Pamoda W. Jayatunga, Eugene Hone, Harjot Khaira, Taciana Lunelli, Harjinder Singh, Gilles J. Guillemin, Binosha Fernando, Manohar L. Garg, Giuseppe Verdile, Ralph Nigel Martins · 2021 · Nutrients
  89. A Mitochondrial Role of SV2a Protein in Aging and Alzheimer’s Disease: Studies with Levetiracetam
    Stockburger, Carola, Miano, Davide, Baeumlisberger, Marion, Pallas, Thea, Arrey, Tabiwang N., Karas, Michael, Friedland, Kristina, Müller, Walter E. · 2016 · Journal of Alzheimer's Disease
  90. Mitochondrial Permeability Transition: A Pore Intertwines Brain Aging and Alzheimer’s Disease
    Kun Jia, Heng Du · 2021 · Cells
  91. SIRT3 in Neural Stem Cells Attenuates Microglia Activation-Induced Oxidative Stress Injury Through Mitochondrial Pathway
    Deqi Jiang, Yan Wang, Mingxing Li, Yanjiao Ma, Yong Wang · 2017 · Frontiers in Cellular Neuroscience
  92. Recent Progress in the Pharmacotherapy of Alzheimer’s Disease
    Rita Khoury, Kush Patel, Jake Gold, Stephanie Hinds, George Thomas Grossberg · 2017 · Drugs & Aging
  93. Modulation of mitochondrial bioenergetics as a therapeutic strategy in Alzheimer's disease
    Isaac G. Onyango · 2018 · Neural Regeneration Research
  94. Altered Slc25 family gene expression as markers of mitochondrial dysfunction in brain regions under experimental mixed anxiety/depression-like disorder
    Vladimir N. Babenko, Дмитрий Александрович Смагин, Anna G. Galyamina, Irina L. Kovalenko, N. N. Kudryavtseva · 2018 · BMC Neuroscience
  95. Alterations of Transcription of Genes Coding Anti-oxidative and Mitochondria-Related Proteins in Amyloid β Toxicity: Relevance to Alzheimer’s Disease
    Magdalena Cieślik, Grzegorz Arkadiusz Czapski, Sylwia Wójtowicz, Iga Wieczorek, Przemysław Leonard Wencel, Robert Piotr Strosznajder, Vivian R. Jaber, Walter J. Lukiw, Joanna Benigna Strosznajder · 2019 · Molecular Neurobiology
  96. Cytochrome P450 Metabolism of Polyunsaturated Fatty Acids and Neurodegeneration
    Morteza Sarparast, Devon A. Dattmore, Jamie K. Alan, Kin Sing Stephen Lee · 2020 · Nutrients
  97. A mechanistic survey of Alzheimer's disease
    Yijing Tang, Dong Zhang, Xiong Gong, Jie Zheng · 2021 · Biophysical Chemistry
  98. Therapeutic efficacy of the Ginkgo special extract EGb761 ® within the framework of the mitochondrial cascade hypothesis of Alzheimer’s disease
    Walter E. Müller, Anne Eckert, Gunter Peter Eckert, Heidrun Fink, Kristina Friedland, Serge G. Gauthier, Robert Hoerr, Ralf Ihl, Siegfried F. Kasper, Hans‐Jürgen Möller · 2017 · The World Journal of Biological Psychiatry
  99. Changes in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study
    Nare Torosyan, Chakmeedaj Sethanandha, Joshua D. Grill, Michelle Dilley, Jooyeon Lee, Jeffrey L. Cummings, Celine Ossinalde, Daniel H.S. Silverman · 2018 · Experimental Gerontology
  100. Mitochondrial dysfunction plays a key role in the development of neurodegenerative diseases in diabetes
    Han Cheng, Xiaokun Gang, Yujia Liu, Gang Wang, Xue Zhao, Guixia Wang · 2019 · American Journal of Physiology-Endocrinology and Metabolism